Navigation Links
Dragon Pharma reports 2010 first quarter financial results
Date:5/17/2010

VANCOUVER, May 17 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG), an international manufacturer of antibiotics, today announced its financial results for the first quarter ended March 31, 2010.

Results for the Quarter Ended March 31, 2010

The Company recorded $49.06 million of revenues for the quarter ended March 31, 2010, representing 33% growth from $36.96 million for the same period of 2009. Net income was $1.58 million, representing 9% increase from $1.45 million for the same period of 2009. Earnings per share (basic and diluted) were $0.02 compared to $0.02 for the same period of 2009.

Sales from the Penicillin Division increased 17% from the same period of 2009 to $14.69 million, accounting for 30% of the Company's total revenues for the first quarter of 2010. The Company expanded its production capacity of Clavulanic Acid in the fourth quarter of 2009 to 135 tons, therefore during the first quarter ended March 31, 2010, sales volume increased 42% to 31 tons from 22 tons for the same period of 2009. Sales from Cefalexin and Cefadrozil, two other main products in the division, decreased 3% from the same period of 2009 mainly due to lower selling prices resulting from oversupply of such products in the Chinese market.

Sales from the Cephalosporin Division increased 41% from the same period of 2009 to $34.37 million, accounting for 70% of the
'/>"/>

SOURCE Dragon Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
2. Strong Demand Pushes up Both Prices and Sales Volumes for Dragons Main Products
3. Dragon Announces R&D Achievement in Biotech Manufacturing Process
4. Dragon announces new product launch; increase in annual production output capacity
5. Dragon retains leading investor relations firm
6. Dragon Pharma announces 2007 full year financial results
7. 3SBio Inc. to Present at The Oppenheimer 2nd Annual China Dragon Call Conference
8. Dragon Pharma Announces June 26, 2008 for 2008 Annual Shareholders Meeting
9. Dragon Pharma Announces Results of the Annual General Meeting
10. Dragon to Present at BioContact Quebec 2008
11. China Biologic Products to Present at CCG IRs China Rising Conference and Oppenheimers China Dragon Call Conference in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... for computing may have just taken an encouraging step ... led by chemist Stephen O,Brien have discovered new complex ... Combining both properties is very exciting scientifically for the ... devices that might ultimately be designed, in logic circuits ... material, however, has proved difficult until now. , Using ...
(Date:9/17/2014)... INCLINE VILLAGE, Nev. , Sept. 17, 2014  PDL ... notified by its independent registered accounting firm, Ernst & Young ... The resignation was confirmed in a letter delivered to the ... 8-K filed on September 16, 2014.  PDL ... "We have received a number of inquiries on ...
(Date:9/17/2014)... N.J. , Sept. 17, 2014 Aethlon ... therapeutic devices to address infectious disease, cancer and other ... (ESI), disclosed today that each company will be presenting ... On September 18 th , Sahil Shah ... "Exosomes: A Multiplexed Platform for Clinical Management." ...
(Date:9/17/2014)... -- BioClinica®, Inc., a leading provider of outsourced clinical ... its experts are speaking at the 20th Annual ... held September 28 to October 1 in ... the innovative Compass technology, a risk-based monitoring ... earlier this year, is up for the Technology ...
Breaking Biology Technology:Oxides discovered by CCNY team could advance memory devices 2PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 2PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 3Aethlon Medical and Exosome Sciences To Present at the Exosomes & SingleCell Analysis Summit 2Aethlon Medical and Exosome Sciences To Present at the Exosomes & SingleCell Analysis Summit 3BioClinica to Present at 20th Annual SCDM Conference 2BioClinica to Present at 20th Annual SCDM Conference 3
... on its recent analysis of new products within the ... the 2012 North American Frost & Sullivan Award for ... a "gold standard" polymerase chain reaction (PCR) instrument. The ... amplification, and detection, all in a multiplexed, automated, and ...
... Inc. (NYSE Amex: BONE ), a leader in ... for medical applications, today announced its financial results for the ... Fourth Quarter 2011 Highlights: Revenue ... for the fourth quarter of 2010. Operating loss decreased ...
... March 21, 2012 When deciding between the ... the upcoming and existing research programs prove highly ... introduces the Life Sciences Content: Pharmaceuticals, Biotechnology, ... to 2012 compendium.  This resource includes Frost ...
Cached Biology Technology:Frost & Sullivan Recognizes iCubate for Developing the New Gold Standard Instrument in the PCR Market 2Frost & Sullivan Recognizes iCubate for Developing the New Gold Standard Instrument in the PCR Market 3Frost & Sullivan Recognizes iCubate for Developing the New Gold Standard Instrument in the PCR Market 4Bacterin Announces Record 2011 Revenue of $30.1 Million; Up 96% Year-over-Year 2Bacterin Announces Record 2011 Revenue of $30.1 Million; Up 96% Year-over-Year 3Bacterin Announces Record 2011 Revenue of $30.1 Million; Up 96% Year-over-Year 4Bacterin Announces Record 2011 Revenue of $30.1 Million; Up 96% Year-over-Year 5Bacterin Announces Record 2011 Revenue of $30.1 Million; Up 96% Year-over-Year 6Bacterin Announces Record 2011 Revenue of $30.1 Million; Up 96% Year-over-Year 7Bacterin Announces Record 2011 Revenue of $30.1 Million; Up 96% Year-over-Year 8Bacterin Announces Record 2011 Revenue of $30.1 Million; Up 96% Year-over-Year 9Bacterin Announces Record 2011 Revenue of $30.1 Million; Up 96% Year-over-Year 10Frost & Sullivan Announces Cutting Edge Life Sciences Research on the Horizon 2Frost & Sullivan Announces Cutting Edge Life Sciences Research on the Horizon 3
(Date:9/16/2014)... 2014)More than $100 trillion in cumulative public and ... dioxide (CO2)a 40 percent reduction of urban passenger ... world expands public transportation, walking and cycling in ... the University of California, Davis, and the Institute ... Further, an estimated 1.4 million early deaths could ...
(Date:9/16/2014)... biology taught us that we inherit certain traits from ... could change how these genes play out by taking ... That,s exactly what a team of researchers at ... through their research of epigenetics research. , Epigenetics ... modifying DNA and histone proteins, which prevent permanent mutations ...
(Date:9/16/2014)... dinosaurs 66 million years ago decimated the evergreens among ... their deciduous peers, according to a study led by ... PLOS Biology . , Applying biomechanical formulas ... of angiosperms flowering plants excluding conifers ... a diverse plant community thriving during a 2.2 million-year ...
Breaking Biology News(10 mins):Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 2Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 3Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 4Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 5Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 2Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 3Meteorite that doomed dinosaurs remade forests 2Meteorite that doomed dinosaurs remade forests 3Meteorite that doomed dinosaurs remade forests 4
... known as 'tandem running' to lead another ant from the ... control both the speed and course of the run. It ... 'formal' teaching has been recognised in any non-human animal. , ... information, rather than the constraint of brain size, that has ...
... Neil Ferguson, and Geoff Garnett (of Imperial College London) ... not be controlled through antiretroviral drugs alone, even if ... article in the open-access international medical journal PLoS Medicine, ... their communities about safe sex, access to drugs is ...
... Hopkins researchers have discovered a gene in fruit flies ... bright light. The study, published in the April 4 ... sensory perception in mammals. , In teasing apart the ... studied a gene they dubbed "Lazaro" that is expressed ...
Cached Biology News:First demonstration of 'teaching' in non-human animals 2Access to antiretrovirals unlikely to reduce HIV infection rates 2New gene reduces retinal degeneration in fruit flies 2
... is essential for hunting and analyzing ... such as EST sequencing projects, microarrays, ... are not well suited for the ... TRIMMER kit, though, is specially developed ...
... SNP loci identification through targeting resequencing. ... design, intensive assay validation/optimization, high throughput ... or customer-supplied samples and sequence alignment ... for rapid and highly accurate identification ...
... Application: The Panorama Mouse/Rat Tissue Extract ... protein expression in various tissue extracts. The ... is detected using a protein specific antibody. ... binding is visualized by a sensitive chemiluminescent ...
... 6 delivers enhanced statistics and statistical ... quality improvement managers. As an accepted ... 6 simplifies statistics for novice users ... by experts. It offers a powerful ...
Biology Products: